Abacus Medicine Pharmaceuticals ApS: Financial statements 2024
CVR: 39192063
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -64,000 and a net result of DKK -2,436,000 compared with DKK 1,385,541 the year before. Equity in the 2024 report amounted to DKK 19,747,000. The solvency ratio was 35.3%.
- Gross Profit
- DKK -64,000
- Profit/Loss
- DKK -2,436,000
- Equity
- DKK 19,747,000
- Total Assets
- DKK 55,940,000
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -64K | -2.4M | 19.7M | 0 |
| 2023 | - | -73K | 1.4M | 22.2M | 0 |
| 2022 | - | -36K | -4.6M | 20.8M | 0 |
| 2021 | - | -43K | 2.8M | 25.4M | 0 |
| 2020 | - | -63K | 188K | 22.6M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2023. Gross profit came to DKK -72,855, and the net result was DKK 1,385,541.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.